Could a drug combo make Kids' foot surgery less painful?
NCT ID NCT07289620
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether adding dexamethasone, dexmedetomidine, or both to a standard numbing shot can make pain relief last longer after foot or ankle surgery in children aged 3 to 12. About 120 kids will get one of three combinations, and neither they nor their doctors will know which. The goal is to see if the combo reduces the need for extra pain medicine and improves comfort.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
dexamethasone and dexmedetomidine
What this could lead to
If it works, this could point toward a better way to manage pain after foot surgery in children, reducing the need for strong painkillers.
What could go wrong
This is a small, early-stage study (120 children) comparing existing drugs, so results may not apply to all patients. The combination might not work better than either drug alone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANKLE DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Poznan University of Medical Sciences
RECRUITINGPoznan, 62-701, Poland
Contact Phone: •••-•••-•••• Email: •••••@•••••